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Abstract— Objective: We present magnetomyograms (MMG) of TMS-evoked movement in a 
human hand, together with a simultaneous surface electromyograph (EMG) and 
electroencephalograph (EEG) data. Approach: We combined TMS with non-contact magnetic 
detection of TMS-evoked muscle activity in peripheral limbs to explore a new diagnostic 
modality that enhances the utility of TMS as a clinical tool by leveraging technological 
advances in magnetometry. We recorded measurements in a regular hospital room using an 
array of optically pumped magnetometers (OPM) inside a portable shield that encompasses 
only the forearm and hand of the subject. Main Results: The biomagnetic signals recorded in 
the MMG provide detailed spatial and temporal information that is complementary to that of 
the electric signal channels. Moreover, we identify features in the magnetic recording beyond 
those of the EMG. Significance: These results validate the viability of MMG recording with a 
compact OPM based setup in small-sized magnetic shielding, and provide proof-of-principle 
for a non-contact data channel for detection and analysis of TMS-evoked muscle activity from 
peripheral limbs.  
 
I. INTRODUCTION 
The central nervous system of the human body forms a critical signaling network that controls 
over 200 muscles1. Developing new technologies that aid in understanding and measuring the 
innervation patterns and muscle activity controlled by this network is crucial for the 
advancement of research, diagnosis and treatment of motor-system diseases like Parkinson’s 
disease and amyotrophic lateral sclerosis (ALS)2,3. One such technology is transcranial 
magnetic stimulation (TMS), which has recently gained widespread use for research and 
diagnosis of various neuropsychiatric disorders4–7. In TMS, a strong magnetic field pulse is 
applied to a specific cortical area. When applied to the motor cortex, TMS results in an evoked 
muscle response in the form of a ‘twitch’8–10. TMS offers a safe, controlled, and non-invasive 
method to investigate the entire motor pathway from motor cortex to muscle, making it an ideal 
platform for studying central motor conduction activity11-13. The TMS-evoked muscle and 
nerve responses in descending motor waves can be recorded with electrophysiological 
measurement techniques such as electromyography14 (EMG), which is considered a gold-
standard tool. The electromyography signal from a muscle stimulated via TMS is known as a 
motor evoked potential (MEP)12. Magnetic signals accompany electrophysiological signals and 
can provide clinically relevant information about innervation and muscle activity that is 
spatially and temporally well resolved15,16. A major challenge is to combine the utility of TMS 
with the stringent operational requirements of state-of-the-art magnetometers. Here, we 
overcome those challenges and record magnetic fields from TMS-evoked muscle activity 
acquired in a regular hospital room using optically pumped magnetometers and small-sized 
magnetic shielding. 
 
Biomagnetic measurements can offer complementary data in TMS-EMG experiments aiming 
to measure evoked muscle activity, since a magnetic response will accompany the changing 
electric field. Surface EMG records electrical potential differences that arise due to 
electromagnetic activity associated with so called motor-unit action potentials (MUAPs), which 
are a summation of individual muscle action potentials that propagate along a single contracted 
muscle fiber14.  The surface EMG does not measure the direct action-potential in the muscle, 
but rather the associated ensemble electromagnetic activity that reaches the skin at a specific 
moment in time. Since electric fields in the body are affected by the conductivity of different 
tissues and specific skin conditions, it can be challenging to recover the exact origin of the EMG 
signal without complex and careful electrode placing and analysis of the specific physiological 
conditions17.  
 
Meanwhile, magnetic fields arise from the composite electrical activity within the body and 
thus also require detailed analysis to recover source information. These fields convey 
information from both the primary MUAPs, as well as the secondary propagation of electrical 
activity through the surrounding biomass. Despite this complication, detailed array 
measurements of the field can also be used to locate the primary sources with excellent 
agreement with established EMG localization techniques18. In this manuscript, we refer to the 
recorded magnetic field signal that arises from a MUAP as a motor evoked field (MEF). 
Importantly, since the relative magnetic permeability of human tissue is close to unity, the 
magnetic fields from MUAPs are directly related to the electro-chemical activity within 
muscles, unaffected by specific conditions of the surrounding tissue19. Crucially, they do not 
rely on a sensor-skin connection. Therefore, while electrical and magnetic signals originate 
from a single event, the difference in how they are communicated to a sensor means that they 
can validate each other and provide complementary information about the system under study. 
In combination with TMS, these magnetic signals can elucidate the proper functioning and 
response of the muscular and central nervous systems20.  
 
FIG. 1: Experimental setup. (a) Schematic of a subject's hand within the innermost magnetic 
shield layer. Sensor positions of the magnetometers and electrodes are indicated. Not indicated 
are mounting/supporting elements or wires. (b) Rendering of experimental setup showing 
subject's hand within the innermost magnetic shield layer and outermost shielding layer. 
Optically pumped magnetometer (OPM) positions are shown in red. (c) Schematic of a 
participant's head with a TMS coil positioned above the motor cortex. (d) Control measurement 
to identify magnetic artifacts in sensor output arising from the TMS pulse. When the participant 
moves their head down, the TMS coil does not stimulate the motor cortex, but the magnetic 
artifact at the sensors is the same as in (c). (e) Motor evoked potentials (MEPs) and motor 
evoked fields (MEFs) were recorded from the right first dorsal interosseus (FDI) muscle during 
TMS (ground electrode is on the index finger). The stimulus results in a lateral `twitch' of the 
right index finger. 
 
Since the detection of magnetic fields does not require physical contact, a magnetic 
measurement of muscle activity, or magnetomyography (MMG)21, is a correspondingly non-
contact technique. These aspects make MMG an attractive tool for complementing EMG, since 
magnetic signals can cross-validate electrophysiological measurements by decoupling signal 
strength from changes in systematic experimental conditions, such as electrode-skin contact for 
electrodes and background magnetic field changes in magnetometers. TMS provides ideal 
conditions for collecting data from these different sensing modalities. Because TMS is a 
repeatable and controlled stimulation, measurements can be triggered and averaged with high 
accuracy in timing, improving the signal-to-noise ratio and repeatability of biomagnetic signals. 
As a result, while information about individual trials is diminished, persistent features across 
repetitive stimulations can be analyzed in detail. 
 
Despite the apparent motivations for magneto-physiological measurements, the very small 
signal size (<10 pT) has limited widespread adoption of biomagnetic measurements as a routine 
clinical measurement, since this regime of sensitivity has been limited to SQUIDs22 
(superconducting quantum interference devices), which require cryogenic cooling. As a result, 
while SQUIDs have been for decades used to detect biomagnetic signals15,23–27, including those 
arising from periphery limbs, the associated measurement systems are bulky, expensive, and 
ill-suited to the different geometries of various body parts, limiting these systems’ practical 
utility. Recent developments in atomic magnetometry have led to high-sensitivity devices 
known as optically pumped magnetometers (OPMs)28 that are uncooled, centimeter-scale, and 
relatively low cost – characteristics necessary to make magneto-physiological measurements 
an accessible diagnostic tool. Additionally, OPMs have opportunities and applications in 
wearable compact devices with wide potential outside of clinical use29. For these reasons, 
OPMs have recently generated broad research interest as a viable alternative to SQUIDs in 
measuring weak biomagnetic signals.  
 
Current OPM technology mandates heating the sensor, resulting in surface temperatures of 
around 40oC, and requires the background magnetic field to be below ~50 nT – well below the 
Earth’s magnetic field and typical noise sources (line noise, equipment noise, elevators, cars, 
etc.). To achieve this precondition, previous studies with OPMs have typically employed 
magnetically shielded rooms, which are incompatible with the intense fields produced by TMS.   
 
In this work, we leverage the advances in OPM technology to enhance the diagnostic utility of 
TMS. Several recent studies have shown that OPMs can detect electrically stimulated muscle 
activity in the hand while in a magnetically shielded environment30,31. Our study represents 
several key advances. First, in using TMS, the evoked muscle activity in this study arises from 
signals that originate with magnetic stimulation at the motor cortex, and therefore involves the 
entire motor pathway, in contrast to electrical stimulation of proximal nerves31. Second, we 
incorporate simultaneous electroencephalography (EEG) during measurements, in addition to 
EMG. Thus, we extend magnetic measurements to an established routine to study repetitive 
TMS evoked activity recorded with EEG and EMG32-34. Finally, we achieve the above stated 
goals in a regular hospital examination room, by using a portable magnetic shield that only 
encompasses the arm of the subject. 
 
With this unique setup, we recorded biomagnetic signals with features that complement and are 
validated by EMG measurements, and furthermore, the magnetometers detect signals from parts 
of the hand that were not covered by the EMG electrodes.  
 
 
 
 
FIG. 2: (a)Thermo-plastic hand molds made for each subject to rest their forearm and hand on 
during the measurement. The plastic is molded around an aluminum support for the forearm. 
The mold section for the index finger is widened to allow for evoked motion due to the TMS. 
(b) Hand mold with a hand. Using flexible VELCRO® strips, the whole mold is suspended 
from an aluminum strut that extends into the magnetic shield. (c) Four commercial OPM 
sensors (QuSpin) arranged on a plastic board that is fit to the magnetic shield. (d) View inside 
the innermost shielding layer, with the eight OPMs seen (four more are behind the red tape at 
the top). Subjects place their forearm on the hand mount, which is then maneuvered into this 
magnetic shield. In contrast to a magnetically shielded room typically required for sensitive 
biomagnetic measurements, our setup avoids potentially claustrophobic conditions.  
 
II. METHODS  
A. Subjects 
All measurements were repeated for four subjects in total, between ages 26 and 40, who 
volunteered for the study. All subjects are right-handed and have no somatic diseases or any 
mental or neurological diseases with confirmed diagnoses. Written informed consent in 
accordance with the Declaration of Helsinki was obtained from all subjects before participation 
in this study, which was approved by the Ethics Committee of the State Medical Association of 
Rhineland-Palatinate. Written informed consent was also obtained from all subjects to publish 
data/images relating to the experiment in an online open-access publication. 
 
B. Experimental procedure  
The OPM and EMG electrode configurations within the shield are shown in Figure 1a-b. The 
measurement preparation time, including control measurements, takes less than 30 minutes. 
The biomagnetic signal is recorded with an array of four OPMs below the hand and an 
additional four above the hand, while the EMG and EEG are simultaneously recorded to 
correlate and provide reference for the signals.  
 
For each participant, the three sensing systems (magnetomyography magnetometers, EMG 
surface electrodes, and EEG electrodes) were prepared and tested individually with the data-
acquisition system. The EEG and EMG were recorded using a 256-channel EGI (Electrical 
Geodesics, Inc.) EEG system and synchronized with OPM data using a trigger signal from the 
TMS pulse. The subject’s hand was positioned inside the shield, and the TMS coil was 
positioned over the subject’s left M1 region (Fig. 1c). The stimulation was applied at different 
frequencies 0.5 Hz, 3 Hz, and 9 Hz for a maximum of up to 3 mins. 
 
The TMS pulse results in a ≈1.4 T field on the motor cortex of the participant, which is less 
than a meter away from the EMG and MMG sensor positions. The sensors record a magnetic 
artifact arising from the TMS pulse, which consists of a bi-phasic pulse lasting approximately 
300 μs. To identify and isolate this artifact, a control measurement was performed in which 
each participant moved their head down (Fig. 1d) and data were taken for the same stimulation 
described above. Since the high-intensity and rapidly changing region of the magnetic field 
from the TMS is highly localized, the induced electrical field and resulting brain activity are 
also limited to a small volume. Therefore, the participants’ change in head position results in 
the absence of a discernible evoked effect, but the magnetic artifact (from the TMS pulse) at 
the sensor is the same as in the experimental conditions. For this control measurement, no MEP 
is observed on the EMG, and a lack of finger ‘twitch’ was confirmed using a camera aimed 
through an access port of the shield. These measurements showed that the artifact lasts up to 15 
ms on the averaged OPM signal – longer than the true pulse due to low-pass filtering in the 
sensor hardware. A small timing jitter in the system leads to artifact signal reduction in 
averaging. Since the jitter (<100 μs) is much smaller than the time-scale of signals of interest 
(>1 ms), this effect does not diminish signal amplitudes. 
 
C. Transcranial magnetic stimulation (TMS) 
To administer TMS, a stimulation coil is placed over of the target area of a participant’s scalp, 
and an electrical current running through the coil results in a region of intense magnetic field 
(up to 1.4 T) within the participant’s brain. This pulsed magnetic field induces a secondary 
electrical current within cortical tissue, which, if within the motor cortex, may result in 
muscular activation33. 
 
The Magstim Super Rapid 2 stimulator (Magstim, UK) with a figure-of-eight coil and internal 
wing diameter of 70 mm was used. The TMS pulse had a bi-phasic waveform and was applied 
at the left primary motor cortex (M1) with an intensity of 110% of the subjects resting motor 
threshold (RMT) (Fig. 1c). The RMT was determined as the minimum stimulus intensity 
required to elicit motor evoked potentials of amplitude 50 μV in 5 out of 10 consecutive trials 
at rest in the contralateral first dorsal interosseous (FDI) muscle (Fig. 1e)12. 
 
D. Optically pumped magnetometry in a portable shield 
Detection of biomagnetic signals requires magnetic sensitivities better than 10 pT/√Hz. The 
commercially available OPMs (QuSpin) used in this work can achieve a noise floor of 15 
fT/√Hz with a bandwidth between 1 - 100 Hz. These sensors operate by optically probing the 
zero-field resonance of spin-polarized rubidium atoms, which is highly sensitive to small 
magnetic fields35. Eight OPM sensors were used and each sensor has two magnetically sensitive 
axes, resulting in a total of 16 magnetic sensor channels.  
 
The main drawback of this magnetometry approach is limited dynamic range, requiring a 
magnetically compensated or shielded background environment in order to reach the sensitivity 
limits, especially when considering a magnetically hostile hospital setting. Most previous 
human biomagnetic measurements using OPMs29-31 were conducted in magnetically shielded 
rooms (MSRs) which typically have residual fields of <10 nT, magnetic gradients on the order 
of 1 nT/m36, and enough space to comfortably accommodate a subject. These characteristics 
constitute an appropriate working environment for OPMs, allowing low-noise measurements 
and some freedom to move the sensors by 1-2 cm37. However, MSRs are expensive and not 
portable, which ultimately restricts the OPM technology to similar limitations as SQUID 
devices. Furthermore, the isolated MSR environment can be unsuitable for subjects to remain 
inside for long measurement times. Importantly, the large magnetic field generated by TMS 
could magnetize and negatively affect the shielding.  
 
To circumvent these practical issues associated with MSR, we instead use a small-sized shield 
that encompasses only the body part relevant to the measurement.  Since we are measuring 
nerve and muscle activity in the hand, the arm of the subject is placed inside a commercially 
available four-layer cylindrical shield (Twinleaf MS-2) with one set of end-caps removed.  The 
missing end-cap compromises the DC shielding by about a factor of 10 within the sensor region, 
however, DC magnetic field offsets (<50 nT at sensor positions) arising in the shield can be 
compensated with the sensors’ compensation coils. Nevertheless, the open-shield modification 
makes the low-field region susceptible to environmental magnetic noise, therefore the ability 
to average over multiple trials is crucial for retaining a high signal to noise ratio (SNR). 
 
Since magnetic-field gradients can be relatively large inside the open shield, the sensors must 
be protected from vibrations or any movement, particularly those that may accompany the 
invoked muscle activity.  Therefore, the subject rests their arm on a custom plastic mold (shown 
in Fig. 2a-b) which is suspended from an aluminum support that extends into the shielded region 
but is otherwise disconnected from the shield and sensors. The subject is thus able to make 
small movements of their hand within the shield without physical disturbance to the sensors 
and causing false signals. This was verified using control measurements in which the suspended 
mold and mount were moved at the expected trigger frequency without a subject arm inside. 
 
Environmental magnetic changes in a hospital setting were measured using a fluxgate 
magnetometer placed outside the shield (Fig. 1e), and while large features (>100 nT on 
fluxgate) were visible on the OPMs, these artifacts were generally sufficiently shielded as to 
not cause the sensor output to go out of range during the measurement.  The effects of these 
low-frequency transient offsets can be minimized by subtracting sensor signals (software 
gradiometry) and averaging. 
 
The complete system, consisting of magnetometers, magnetic shielding, hand mounting 
supports, and all associated data acquisition equipment was transported by vehicle to the 
hospital and deployed within two hours. 
 
Relevant photographs of the experimental equipment and setup are shown in Figure 2. 
 
E. Electroencephalography and electromyography 
To validate the utility of OPMs in TMS measurements, we maintain existing experimental 
protocols which combine TMS with EMG and EEG12,38. 
 
The EEG signals were recorded with a high-density (256 electrodes) EEG system (Net Station 
5.0, EGI, USA). The caps were placed manually with the Cz electrode positioned over a 
centralized location on the scalp, which was determined as the simultaneous midpoint of the 
arc length for both nasion-inion and preauricular arcs. The electrode impedances were kept 
under 50 kOhm throughout the experiment38-40, and a sampling frequency of 1000 Hz was used. 
The surface EMG was recorded from the FDI muscles. Both the EEG and EMG were digitized 
with a single amplifier. The amplifier applies a bandpass filter (low frequency cutoff 0.1 Hz, 
high frequency cutoff 70 Hz), and a notch filter (50 Hz) to the EEG. Similarly, a bandpass filter 
(low frequency cutoff 0.5 Hz, high frequency cutoff 500 Hz), and a notch filter (50 Hz) were 
applied to the EMG. 
 
F. Data analysis 
The EMG-electrode data were extracted and partially analyzed using open-source Python 
software (MNE)41,42. The TMS-evoked potentials (TEP) were computed from the analysis of 
EEG data using Matlab 2015b and the Fieldtrip toolbox (http://www.fieldtriptoolbox.org/). The 
exact details of the pre-processing steps and analysis have been described elsewhere41.  
 
All the magnetometer data from each participant were analyzed using a custom Python code 
for cutting and averaging based on the TMS trigger signal. After each trigger, one second of 
acquired data is defined as a single trial. Since the noise within a single trial is too large (due to 
the magnetically hostile hospital environment) to see clear biomagnetic signals, multiple trials 
must be averaged together in order to achieve good signal to noise. Notch filters were applied 
at 50 Hz (Q=20) and higher harmonics, and the data were smoothed with an evenly weighted 
four-point moving window. Smoothing is preferred over low-pass filtering to avoid filter 
artifacts that would arise from the sharp TMS pulse.  
 
The latency of the MEP (recorded from EMG channels) or the MEF from magnetic sensors 
provides important information about the nerve transmission speed. To extract latency values, 
a mathematical fitting function consisting of a double Gaussian with linear offset was chosen 
to fit the averaged data, since this would establish a repeatable and consistent way to compare 
the signal quality vs. the number of averages. The double Gaussian function that the data were 
fit to is defined as, 
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2
2σ1
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−(𝑥−𝑥2)
2
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2 + 𝑦0 +𝑚 × 𝑥 , 
 
 
where A1 and A2 are the individual Gaussian amplitudes, x1 and x2 and respective offsets, σ1 and 
σ2 are the Gaussian widths, y0 is an offset and m is the linear slope. The fit parameters y0 and m 
capture the decaying artifact from the TMS pulse that overlaps the MEF signal. This fit was 
chosen as best able to capture the bi-phasic signal and extract a consistent value for the latency 
between the stimulus to the onset of the action potential but has no particular physical meaning. 
The fit was made around 25 ms after the trigger. This offset time window was chosen to 
coincide with the MEF latency and to avoid fitting the artifact. The latency is then defined as 
x1−2.5σ1, where x1 is the center offset value of the first fitted Gaussian, and σ1 is the half-width-
half-max of the fit. The value of 2.5σ1 represents a reliable point at which the data rises 
approximately to 5% of the Gaussian amplitude of the signal, defining a consistent value of the 
latency unbiased by manually chosen values. This fit was used for both the electric and 
magnetic data. 
 
FIG. 3: Combined EEG, EMG and MMG data for a single participant, showing relative detail 
in magnetic vs. electromyography signals, and how the data from three input methods in the 
experimental system complement each other. (a) 120 averages of MMG and EMG data before, 
during and after the TMS pulse (occurring at 0.0 s). Following the large artifact at the TMS 
pulse, magnetic activity in the hand is detected for approximately 300 ms in this subject, which, 
based on control measurements, was not attributable to vibration. (b) Zoom of the data in (a) 
for the time period immediately following the TMS pulse. EMG channel has been offset so as 
not to obstruct the MMG channels. The magnetic sensors detect both activity which coincides 
with the electric channel, and which occurs while the electric channel shows nothing. Eight of 
16 magnetic sensor channels were selected based on noise levels and signal amplitude. 
Referencing Fig. 1a: MMG1, magnetometer AC; MMG2, magnetometer 9P; MMG3, 
magnetometer AB; MMG4, magnetometer 9O. (c) EEG topograms of brain activity during 
selected points after the TMS pulse. The topograms were analyzed at times where magnetic 
features had largest amplitude. Brain activity begins in the motor cortex where the TMS pulse 
is applied. The activity then moves to other regions of the brain over the course of the 
measurement. 
 
III. RESULTS AND DISCUSSION 
Averaged data resulting from 120 repetitive TMS pulses at 0.5 Hz with a single participant are 
shown in Figure 3. While 16 magnetic sensor channels are available from the experiment, we 
select the eight shown for clarity and consistency across subjects because some sensors failed 
(out of range due to environment) during measurements. The sensors shown [y- and z- axes 
from magnetometers MMG1(AC), MMG2(9P), MMG3(AB) and MMG4(9O)] are positioned 
below and above the hand, respectively. In Figure 3(a), the signals from both the EMG and 
MMG are shown to occur within 300 ms of the TMS pulse, with little discernible activity 
thereafter. During the TMS magnetic artifact, which is a homogenous field modulation over the 
magnetometer array, the y and z sensors record large features with the same sign, indicating that 
fields at these sensors are oriented similarly. 
 
Figure 3(b) shows a narrower time window, where both magnetic and electric (shown in red) 
channels exhibit peaks at 26 ms. On the EMG channel, this feature is identified as the MEP12, 
and there is good agreement in the signal latency calculated from electric and magnetic 
channels. The magnetic field feature associated with the MEP, which we identify as the MEF, 
was observed in recordings from all four subjects. On the MMG channel, the relative sign and 
shapes of the magnetic features in the data could be used to inform source location of the muscle 
activity26. 
 
Starting at around 50 ms after the TMS pulse, the magnetometer channels record a bi-phasic 
feature that lasts up to 200 ms. This larger magnetic signal does not appear on the EMG but is 
observable across subjects’ MMG recordings. Based on control measurements, this signal is 
not attributable to vibrations in the system. These features may result from muscle activity 
arising in other parts of the hand that are not covered by the EMG electrodes, indicating that 
MMG can be used to map out which muscles are activated in repetitive TMS. Alternatively, the 
signal is consistent with an H-reflex and the loss of this H-reflex signal in EMG recording could 
be due to the choice of filter parameters implemented in this study43. Future studies will focus 
on identifying the source of these additional features in the magnetic signal. 
 
The MMG data are used to identify the time points after the TMS pulse at which to examine 
the EEG topology plots, shown in Figure 3c. Further study is needed to establish the relationship 
between the MMG and EEG, but the points here are chosen as times of interest, demonstrating 
that data from the different signal channels are comparable. At the topology plot data at 26 ms, 
corresponding to the time of the MEF, electrical activity in the brain was observed at the 
location of the TMS stimulus, in the M1 region. At later times, 86 ms and 180 ms, this activity 
moved to contralateral M1 and parietal regions, respectively.  Furthermore, the results showed 
similar patterns in other subjects (Figure 4). These results confirm that TMS induces focal 
effects, and these effects spread to other brain regions beyond the stimulated region44, at 
timescales similar to the periphery magnetic response.   
 
 
FIG. 4: Combined MMG, EMG, and EEG data for four participants. Variability across subjects 
is clearly discernible in the MMG data, but all show qualitatively similar results for all signal 
types. The shape of the TMS artifact is strongly dependent on the position of the TMS coil 
relative to the magnetic shield, which varies from participant to participant. Additionally, the 
actual duration of the TMS pulse is ~300 µs. The TMS artifact is distorted due to sensor 
bandwidth, low sampling, low-pass filtering, and timing jitter between the pulse and the 
sampling trigger. Note: The EMG electrode from Subject 1 was found afterwards to have been 
improperly grounded, leading to large noise artifacts that remained after filtering and 
smoothing. Nevertheless, the MEP is still visible. 
 
Figure 4 shows the TMS-invoked magnetic and electric response of the hand for four subjects. 
Each subject has a unique magnetic signal – for example, data from Subject 1 shows magnetic 
field values that are almost three times as large as those of the other subjects. Inter-subject 
variability during TMS could account for variability in the EMG and MMG recordings45. For 
both EMG and MMG, variability was calculated by removing any constant or linear offsets 
from the signal and taking the root-mean-square value of the signal between the TMS trigger 
and 500 ms post trigger. The variation from the mean for each subject was calculated and the 
average variability for all four subjects is 28% in EMG recordings, and 34% for MMG 
recordings. Variability in the magnetic recordings is greater than that of the EMG. This could 
result from the fact that the magnetic signal is strongly dependent on the distance between 
source and sensor, which varies based on the subject physiology. Inter-trial variation could not 
be calculated because of inadequate signal-to-noise-ratio. The poor SNR arises due to operating 
the OPMs in the open shield, which results in a residual noise amplitude of ~10 pT before 
averaging.  
 
Data from all the participants show that the MEP from the EMG is observed as a corresponding 
MEF in the magnetometer channels. Finally, the EEG result shows qualitatively similar 
behavior of the brain activity across subjects at the time points chosen based on features in the 
MMG. 
 
Latency analysis demonstrates the complementarity of MMG to EMG signals in TMS 
measurements. There is good agreement between the latencies extracted from MMG or EMG 
measurements (Table 1), and the magnetic field measurement offers important validations of 
the electrical potential measurement. For example, EMG data can be influenced by a variety of 
factors involving the electrode-skin contact, including transient changes such as changing 
electrode impedance due to increases or decreases in skin moisture during the measurement and 
changing noise floors46. While the specific geometry of the source determines the magnetic 
field at the sensor, the near unity permittivity of tissue or bone means that it conveys the 
absolute value of the field from the source, and that it could be used to decouple changing 
systematic experimental conditions between measurements. In our data set, the MMG data 
suffers from inadequate SNR to perform such analysis on a trial-by-trial basis. Repeatable 
latency values could be extracted for signals averaged from at least 45 trial windows, indicating 
that this is the minimum number of trials needed.  
 
Table 1: Comparison of MEP vs. MEF latency for each subject. Uncertainty, shown in 
parentheses, was calculated from covariance matrix of the fitted Gaussian function after full 
averaging of all trials. Uncertainty for the average is standard deviation of the four subjects. For 
Subject 4, there is a 1 standard-deviation discrepancy in the timing of the signal as measured 
from electric and magnetic channels. The good agreement in the averages indicates that there 
is not a statistically significant systematic over- or under- reporting of one method relative to 
the other. 
 MMG [ms] EMG [ms] 
Subject 1 26(1) 25(1) 
Subject 2 20(2) 20(1) 
Subject 3 18(2) 19(2) 
Subject 4 22(1) 20(1) 
Average 22(3) 21(2) 
 
 
IV. CONCLUSION 
A. Future Work 
Future work will mainly focus on increasing the SNR through implementing and optimizing 
active magnetic field compensation and software gradiometry. As discussed, MMG could also 
aid in identifying and locating TMS activated muscles that are not in regions probed by surface 
electrodes. In this work, the relative position between sensors and hand was not adequately 
controlled to perform reliable inversion of the field to acquire the source location. However, in 
future work, better sensor array positioning and hand position indicator methods similar to 
systems widely used in EEG, will be applied to achieve the high resolution widely demonstrated 
in the literature47-49. Another direction will be in combining the analysis of different system 
aspects, in order to probe possible connections between signals from different input channels.  
 
B. Significance 
These first results of OPM-recorded magnetic signals from TMS-evoked movement 
demonstrate the future viability of the TMS-OPM system for clinical research. We showed that 
magnetic field sensing of periphery limbs is possible in a regular hospital using small magnetic 
shields, circumventing the requirement for a large and expensive magnetically shielded room, 
which has been a pre-requisite for previous studies. The combined use of magnetic and electric 
field sensors allows for detailed validation of different signals, while providing complementary 
information about muscle activity in the hand. TMS is targeted, repeatable and safe, and thus 
can be used in future studies to identify the innervation pathways for specific muscles in various 
locations along the arm, by using the magnetic data for magnetic source imaging. 
 
Together with small-sized magnetic shielding, the portable and economical commercial OPM 
systems can enhance the utility of TMS. We demonstrated a complete MMG system that could 
be transported and deployed within several hours, with subject preparation times for the MMG 
within minutes. This approach represents a new modality in TMS research with opportunities 
for peripheral nerve study. 
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